MBT Financial Corp. Announces Dividend and Preliminary Fourth Quarter 2018 Highlights
MONROE, Mich., Jan. 28, 2019 (GLOBE NEWSWIRE) — MBT Financial Corp. (NASDAQ: MBTF), the parent company of Monroe Bank & […]
II-VI Incorporated to Showcase a Broad Range of Innovations at Photonics West 2019
PITTSBURGH, Jan. 28, 2019 (GLOBE NEWSWIRE) — II-VI Incorporated (NASDAQ:IIVI), a global leader in engineered materials and optoelectronic components, today […]
Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2019 Animal Health Summit
TEANECK, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) — Phibro Animal Health Corporation (NASDAQ:PAHC) Chairman, President and Chief Executive Officer Jack […]
Independent Bank Group, Inc. Reports Fourth Quarter Financial Results
MCKINNEY, Texas, Jan. 28, 2019 (GLOBE NEWSWIRE) — Independent Bank Group, Inc. (NASDAQ: IBTX), the holding company for Independent Bank, […]
Veritex Holdings, Inc. Announces Stock Buyback Program
DALLAS, Jan. 28, 2019 (GLOBE NEWSWIRE) — The Board of Directors (the “Board”) of Veritex Holdings, Inc. (Nasdaq: VBTX) (the […]
Northeast Bancorp Reports Second Quarter Results and Declares Dividend
LEWISTON, Maine, Jan. 28, 2019 (GLOBE NEWSWIRE) — Northeast Bancorp (“Northeast” or the “Company”) (NASDAQ: NBN), a Maine-based full-service financial […]
Veritex Holdings, Inc. Declares Cash Dividend on Common Stock
DALLAS, Jan. 28, 2019 (GLOBE NEWSWIRE) — Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or the “Company”), the parent holding company […]
Comstock Resources Announces Fourth Quarter 2018 Earnings Date and Conference Call Information
Frisco, TX, Jan. 28, 2019 (GLOBE NEWSWIRE) — COMSTOCK RESOURCES, INC. ANNOUNCESFOURTH QUARTER 2018 EARNINGS DATE AND CONFERENCE CALL […]
TrackX Reports Q4 and Fiscal 2018 Financial Results
Land and Expand Strategy is Setting up a Strong F2019 Pipeline DENVER, Jan. 28, 2019 (GLOBE NEWSWIRE) — TrackX Holdings […]
IMV to Present at 2019 BIO CEO & Investor Conference
DARTMOUTH, Nova Scotia, Jan. 28, 2019 (GLOBE NEWSWIRE) — IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, […]
